CDB25:0004318 SMOC2 — LRP6

Experimentally validated in Human; Orthology-inferred in Mouse, Rat, Frog, Zebrafish, Chicken, Macaque, Pig, Dog, Cow, Chimp, Horse, Marmoset, Sheep

Title

Journal:; Year Published:

Abstract

Targeting cancer stem cell signature gene SMOC-2 Overcomes chemoresistance and inhibits cell proliferation of endometrial carcinoma.

EBioMedicine, 2019; PubMed, Homo sapiens SMOC2 — Homo sapiens LRP6
ABSTRACT: Endometrial cancer is one of the most common gynecological malignancies and has exhibited an increasing incidence rate in recent years. Cancer stem cells (CSCs), which are responsible for tumor growth and chemoresistance, have been confirmed in endometrial cancer. However, it is still challenging to identify endometrial cancer stem cells to then target for therapy.
Basic Information on SMOC2
Ligand Name: SPARC related modular calcium binding 2
Other Symbols: SMAP2
Ligand Location: secreted based on perplexity, uniprot
HGNC Gene Symbol Report: SMOC2
GeneCards: SMOC2
HGNC Gene Group: EF-hand domain containing
Interactions with other Receptors for SMOC2
Basic Information on LRP6
Receptor Name: LDL receptor related protein 6
Other Symbols: ADCAD2
Receptor Location: cell membrane based on perplexity, uniprot
HGNC Gene Symbol Report: LRP6
GeneCards: LRP6